Data / Form D filings / Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc.: Form D filings
Cidara Therapeutics, Inc., a biotechnology company in San Diego, CA, filed 7 Form D notices with the SEC between 2014 and 2024. The latest, on May 6, 2024, reports $240 million sold of a $240 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6310 NANCY RIDGE DRIVE, SUITE 101, San Diego, CA, 92121
- Phone
- (858) 752-6170
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1610618
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2024 | New notice | $240,000,000 | $240,000,000 | 7 | Apr 24, 2024 | sec.gov | |
| Sep 13, 2019 | New notice | $9,008,173 | $9,008,173 | 1 | Sep 3, 2019 | sec.gov | |
| May 30, 2018 | New notice | $1,874,999 | $1,562,499 | $312,500 | 16 | May 23, 2018 | sec.gov |
| Oct 31, 2017 | New notice | $20,160,000 | $20,160,000 | 16 | Oct 24, 2017 | sec.gov | |
| Feb 17, 2015 | New notice | $42,019,999 | $42,019,999 | 19 | Feb 10, 2015 | sec.gov | |
| Jun 17, 2014 | New notice | $42,743,763 | $30,332,199 | $12,411,564 | 8 | May 30, 2014 | sec.gov |
| Jun 17, 2014 | New notice | $6,000,472 | $6,000,472 | 1 | May 30, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carin R. Canale-Theakston | Director | |
| Theodore R. Schroeder | Director | |
| Daniel D. Burgess | Director | |
| Laura R. Tadvalkar, Ph.D. | Director | |
| Taylor R. Sandison, M.D. | Executive Officer | |
| Leslie R. Tari, Ph.D. | Executive Officer | |
| Preetam R. Shah, Ph.D. | Executive Officer | |
| Bonnie R. Bassler, Ph.D. | Director | |
| James R. Merson, Ph.D. | Director | |
| Ryan R. Spencer | Director | |
| Shane R. Ward | Executive Officer | |
| Jeffrey Stein, Ph.D. | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 6, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cidara Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.